Skip to main content

Day: September 19, 2024

Novo Nordisk A/S: Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function

Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical functionWegovy® (semaglutide 2.4 mg) is the first obesity medication to receive a positive opinion recommending a label update that reflects reduced symptoms and improved physical limitations and exercise function in people with obesity-related heart failure with preserved ejection fraction (HFpEF).The positive opinion is based on results from the STEP HFpEF and STEP HFpEF-DM trials, which showed that Wegovy® is an effective therapy compared to placebo for people with obesity-related HFpEF.1,2Bagsværd, Denmark, 19 September 2024 – Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for an...

Continue reading

MineSense XRF Scanning Testwork Confirms Ore Sorting Applicability at CuMo

Idaho Copper CorporationMineSense XRF shovel-based sensorsIdaho Copper CorporationMineSense XRF shovel-based sensorsBoise, Idaho, Sept. 19, 2024 (GLOBE NEWSWIRE) — Idaho Copper Corp. (OTC Pink: COPR) is pleased to announce that it has received initial results from scanning and amenability testwork performed using MineSense XRF scanning technology from representative samples of the three main geological zones at the CuMo Idaho copper-molybdenum-silver deposit. These samples were tested by MineSense at its Vancouver, BC, Canada facility, and involved a series of simulations:First, run of mine ore samples from each zone were repeatedly sent (ten times) through the MineSense XRF sensor ATM system, which replicates a mining shovel bucket Next, the ore was crushed to

Continue reading

UniFirst Corporation Announces Leadership Changes: Kelly Rooney Named Chief Operating Officer and Michael Croatti to Transition from Executive Role

WILMINGTON, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — UniFirst Corporation (NYSE: UNF), a North American leader in the supply and servicing of uniform and workwear programs, facility service products, and first aid and safety supplies, is pleased to announce the appointment of Kelly Rooney as Chief Operating Officer (COO), effective September 30, 2024. Rooney has extensive knowledge and experience in large-scale B2B route-based operations. Over her twenty-five plus year career, she has held operational and leadership roles of increasing responsibility. Her most recent position was as the Chief Human Resources Officer at Waste Management, a $20 billion public company. Rooney is returning to her roots and will oversee UniFirst’s day-to-day operations, focusing on driving growth, enhancing customer service excellence, and executing...

Continue reading

Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments

Gimoti remains the sole proprietary FDA approved treatment for symptoms of diabetic gastroparesis SOLANA BEACH, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on Gimoti® (metoclopramide) nasal spray, reaffirms its commitment to improving the lives of patients suffering from diabetic gastroparesis in light of the recent decision by the U.S. Food and Drug Administration (FDA) to not approve Vanda Pharmaceuticals new drug application (NDA) for Tradipitant, an oral drug candidate for the treatment of symptoms in gastroparesis. Patients suffering from all forms of gastroparesis need additional agents to help treat this difficult disease, and we believe patients will be disappointed given...

Continue reading

Bright Green Corporation Provides an Update, Reinforces Commitment to Shareholders, and Focuses on Growth and Strategic Partnerships

GRANTS, NEW MEXICO, Sept. 19, 2024 (GLOBE NEWSWIRE) — Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or the “Company”), today announced that trading of its shares have been suspended from the Nasdaq Stock Exchange (“Nasdaq”) after Nasdaq cancelled the scheduled September 26, 2024 delist appeal hearing. While this development represents a change in the Company’s public trading status, Bright Green remains committed to pursuing its strategic goals and delivering value to its shareholders. The Company filed its Proxy Statement and will proceed with its scheduled annual meeting on November 15, 2024, during which shareholders will discuss key issues, including the potential for a reverse stock split aimed at enhancing shareholder value and positioning the Company for future success. In addition to these efforts, the Company...

Continue reading

SAVENCIA: 2024 half-yearly results

        Thursday, September 19, 2024 Press Release: 2024 half-yearly results  Solid operating performances  Key figures in €M   30/06/24   % of sales   30/06/23   % of sales   % changesTotal Structure Change & IAS 29 Organic growth (1)Sales 3,380   3,376   0.1 1.9 -2.6 0.8– Cheese Products 1,920 56.8 1,934 57.3 -0.7 0.0 -0.8 0.2– Others Dairy Products 1,578 46.7 1,552 46.0 1.7 4.2 -4.9 2.4– Unallocated -118 -3.5 -110 -3.2 7.6 0.2 -5.2 12.6Current Operating Profit 110 3.3 112 3.3          Operating profit 103 3.0 98 2.9          Financial result -21   -15            Corporate taxes -25   -28            Result for the period 64 1.9 58 1.7          Net income, Group share 58 1.7 51 1.5          Net debt (excluding IFRS 16) 438   600            First-half 2024 financial...

Continue reading

SRIVARU Holding Limited Secures Nasdaq Panel Approval for Continued Listing Amid Compliance Efforts

GRAND CAYMAN, Cayman Islands, Sept. 19, 2024 (GLOBE NEWSWIRE) — SRIVARU Holding Limited (Nasdaq: SVMH, SVMHW) (“SRIVARU” or the “Company”), a leading innovator in the electric motorcycle market, today announced that it has received a favorable decision from the Nasdaq Hearings Panel (the “Panel”). The Panel’s decision grants the Company’s request for continued listing on Nasdaq, which we believe will provide SRIVARU the necessary time to implement its plan to regain compliance with Nasdaq’s listing requirements. Following the Company’s hearing on September 5, 2024, the Panel has stipulated specific conditions for continued listing. SRIVARU must fulfill the below requirements by November 14, 2024:Submitting a public filing and financial statements that confirm the Company meets Nasdaq’s shareholder...

Continue reading

Sodexo – Disclosure of transactions in own shares carried out from September 16 to September 17, 2024

Regulated InformationIssy-les-Moulineaux, September 19, 2024 DISCLOSURE OF TRANSACTIONS IN OWN SHARES CARRIED OUT FROM SEPTEMBER 16 TO SEPTEMBER 17, 2024 Sodexo purchased treasury shares, outside of its liquidity contract, within the framework of its share buyback program as authorized by the Shareholders’ Meeting held on December 15, 2023. These shares have been acquired to honor obligations related to free shares award plans. Information on these transactions are the following:Trading date LEI ISIN Volume(in number of shares) Weighted average purchase price (in euros) Market           16/09/2024 969500AGKR3PRJG4WD05 FR0000121220 12,472 77.9203 XPAR16/09/2024 969500AGKR3PRJG4WD05 FR0000121220 11,690 78.0104 CEUX16/09/2024 969500AGKR3PRJG4WD05 FR0000121220 2,000 77.9691 TQEX16/09/2024 969500AGKR3PRJG4WD05 FR0000121220 1,774 77.899 AQEU17/09/2024 969500AGKR3PRJG4WD05 FR0000121220 9,519 78.543 XPAR17/09/2024 969500AGKR3PRJG4WD05 FR0000121220 5,700 78.5788 CEUX17/09/2024 969500AGKR3PRJG4WD05 FR0000121220 500 78.6348 TQEX17/09/2024 969500AGKR3PRJG4WD05 FR0000121220 500 78.6501 AQEU                          Total 44,155 78.1811             Detailed...

Continue reading

AKWEL: FIRST-HALF 2024 NET INCOME OF €20.2M

        Champfromier, Thursday, September 19, 2024 FIRST-HALF 2024 NET INCOME OF €20.2MRecurring operating margin of 4.6% of sales Net cash position of €106 million at June 30, 2024AKWEL (FR0000053027, AKW, PEA eligible), a systems supplier to the automotive and truck industries, specializing in fluid management, mechanisms and structural parts for electric vehicles, announces its half-year results for 2024, approved by the Board on September 18, 2024. The audit reports are currently being issued.Consolidated data – In M€ 30.06.2024 30.06.2023 30.06.2023retired (1) % change/ retiredSales figures 528,8 533,2 545,8 -3,1 %Gross operating surplus 49,2 49,0 49,8 -1,3 %Current operating income 24,4 30,2 31,1 -21,6 %Operating margin before non-recurring items 4,6 % 5,7 % 5,7 % -1.1 ptsOperating income 28,9 30,0 30,6 -5,4...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.